These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 26320059)

  • 1. Anticancer Cytokines: Biology and Clinical Effects of Interferon-α2, Interleukin (IL)-2, IL-15, IL-21, and IL-12.
    Floros T; Tarhini AA
    Semin Oncol; 2015 Aug; 42(4):539-48. PubMed ID: 26320059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The combination of IL-21 and IFN-alpha boosts STAT3 activation, cytotoxicity and experimental tumor therapy.
    Eriksen KW; Søndergaard H; Woetmann A; Krejsgaard T; Skak K; Geisler C; Wasik MA; Odum N
    Mol Immunol; 2009 Feb; 46(5):812-20. PubMed ID: 18947877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The IL-2 cytokine family in cancer immunotherapy.
    Sim GC; Radvanyi L
    Cytokine Growth Factor Rev; 2014 Aug; 25(4):377-90. PubMed ID: 25200249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunotherapy for renal cell carcinoma.
    Rosenblatt J; McDermott DF
    Hematol Oncol Clin North Am; 2011 Aug; 25(4):793-812. PubMed ID: 21763968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer treatment with interleukins 1, 4 and 6 and combinations of cytokines: a review.
    Dullens HF; De Wit CL
    In Vivo; 1991; 5(6):567-70. PubMed ID: 1810440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms and applications of interleukins in cancer immunotherapy.
    Anestakis D; Petanidis S; Kalyvas S; Nday CM; Tsave O; Kioseoglou E; Salifoglou A
    Int J Mol Sci; 2015 Jan; 16(1):1691-710. PubMed ID: 25590298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antitumoral action of interferons and interleukins in combination with radiotherapy. Part I: immunologic basis].
    Herskind C; Fleckenstein K; Lohr J; Li CY; Wenz F; Lohr F
    Strahlenther Onkol; 2004 Apr; 180(4):187-93. PubMed ID: 15057428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukins and cancer immunotherapy.
    Yoshimoto T; Morishima N; Okumura M; Chiba Y; Xu M; Mizuguchi J
    Immunotherapy; 2009 Sep; 1(5):825-44. PubMed ID: 20636026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination strategies for enhancing the efficacy of immunotherapy in cancer patients.
    Moschella F; Proietti E; Capone I; Belardelli F
    Ann N Y Acad Sci; 2010 Apr; 1194():169-78. PubMed ID: 20536466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenovirus-mediated interleukin (IL)-24 immunotherapy for cancer.
    Ramesh R; Ioannides CG; Roth JA; Chada S
    Methods Mol Biol; 2010; 651():241-70. PubMed ID: 20686970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances on the immunomodulatory effects of IFN-alpha: implications for cancer immunotherapy and autoimmunity.
    Rizza P; Moretti F; Belardelli F
    Autoimmunity; 2010 Apr; 43(3):204-9. PubMed ID: 20187707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokine-based Cancer Immunotherapy: Challenges and Opportunities for IL-10.
    Rallis KS; Corrigan AE; Dadah H; George AM; Keshwara SM; Sideris M; Szabados B
    Anticancer Res; 2021 Jul; 41(7):3247-3252. PubMed ID: 34230118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Favorable alteration of tumor microenvironment by immunomodulatory cytokines for efficient T-cell therapy in solid tumors.
    Tähtinen S; Kaikkonen S; Merisalo-Soikkeli M; Grönberg-Vähä-Koskela S; Kanerva A; Parviainen S; Vähä-Koskela M; Hemminki A
    PLoS One; 2015; 10(6):e0131242. PubMed ID: 26107883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update on the role of interleukin 2 and other cytokines in the treatment of patients with stage IV renal carcinoma.
    Atkins MB; Regan M; McDermott D
    Clin Cancer Res; 2004 Sep; 10(18 Pt 2):6342S-6S. PubMed ID: 15448028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of cytokine therapy in 2006 and beyond for metastatic renal cell cancer.
    Parton M; Gore M; Eisen T
    J Clin Oncol; 2006 Dec; 24(35):5584-92. PubMed ID: 17158544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antitumor immunotherapy].
    Błoński JZ; Warzocha K
    Postepy Hig Med Dosw; 1994; 48(6):701-28. PubMed ID: 7675731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination nonviral interleukin-2 gene immunotherapy for head and neck cancer: from bench top to bedside.
    O'Malley BW; Li D; McQuone SJ; Ralston R
    Laryngoscope; 2005 Mar; 115(3):391-404. PubMed ID: 15744147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokines in the Treatment of Cancer.
    Conlon KC; Miljkovic MD; Waldmann TA
    J Interferon Cytokine Res; 2019 Jan; 39(1):6-21. PubMed ID: 29889594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular immunological approaches to biotherapy of human cancers--a review, hypothesis and implications.
    Becker Y
    Anticancer Res; 2006; 26(2A):1113-34. PubMed ID: 16619514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokines in Cancer Immunotherapy.
    Waldmann TA
    Cold Spring Harb Perspect Biol; 2018 Dec; 10(12):. PubMed ID: 29101107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.